Teleflex Incorporated
Teleflex Incorporated (TFX) Financial Performance & Income Statement Overview
Explore the financials of Teleflex Incorporated (TFX), including yearly and quarterly data on income, cash flow, and balance sheets.
Teleflex Incorporated (TFX) Income Statement & Financial Overview
View the income breakdown for Teleflex Incorporated TFX across both annual and quarterly reports.
Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
---|---|---|---|---|
Revenue | $780.89M | $700.67M | $795.41M | $764.38M |
Cost of Revenue | $349.80M | $311.23M | $355.49M | $334.20M |
Gross Profit | $431.08M | $389.44M | $439.92M | $430.17M |
Gross Profit Ratio | $0.55 | $0.56 | $0.55 | $0.56 |
R&D Expenses | $38.52M | $36.40M | $44.55M | $38.73M |
SG&A Expenses | $215.08M | $222.71M | $254.55M | $247.26M |
Operating Expenses | $253.60M | $263.87M | $559.50M | $285.98M |
Total Costs & Expenses | $603.41M | $575.10M | $905.79M | $620.19M |
Interest Income | -$1.64M | $1.92M | $2.26M | $2.30M |
Interest Expense | $21.71M | $18.54M | $18.64M | $21.06M |
Depreciation & Amortization | $0.00 | -$32.38M | $71.79M | $68.64M |
EBITDA | $122.58M | $95.10M | -$36.33M | $220.25M |
EBITDA Ratio | $0.16 | $0.14 | -$0.05 | $0.29 |
Operating Income | $122.58M | $125.57M | -$110.38M | $149.31M |
Operating Income Ratio | $0.16 | $0.18 | -$0.14 | $0.20 |
Other Income/Expenses (Net) | $12.66M | -$16.63M | -$16.38M | -$18.76M |
Income Before Tax | $135.25M | $108.94M | -$126.76M | $130.55M |
Income Before Tax Ratio | $0.17 | $0.16 | -$0.16 | $0.17 |
Income Tax Expense | $12.66M | $13.84M | $9.90M | $19.63M |
Net Income | $122.58M | $95.002M | -$136.66M | $111.004M |
Net Income Ratio | $0.16 | $0.14 | -$0.17 | $0.15 |
EPS | $2.77 | $2.08 | -$2.95 | $2.38 |
Diluted EPS | $2.77 | $2.07 | -$2.95 | $2.36 |
Weighted Avg Shares Outstanding | $44.27M | $45.78M | $46.32M | $46.72M |
Weighted Avg Shares Outstanding (Diluted) | $44.33M | $45.93M | $46.37M | $47.01M |
Over the past four quarters, Teleflex Incorporated demonstrated steady revenue growth, increasing from $764.38M in Q3 2024 to $780.89M in Q2 2025. Operating income reached $122.58M in Q2 2025, maintaining a consistent 16% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $122.58M, reflecting operational efficiency. Net income rose to $122.58M, with EPS at $2.77. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan